000			01903 a2200505 4500
005			20250515031229.0
264		0	_c20061026
008			200610s 0 0 eng d
022			_a0165-5728
024	7		_a10.1016/j.jneuroim.2006.05.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aSaurer, Timothy B
245	0	0	_aNeuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. _h[electronic resource]
260			_bJournal of neuroimmunology _cAug 2006
300			_a18-26 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnti-Anxiety Agents _xpharmacology
650	0	4	_aArginine _xanalogs & derivatives
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Interactions _xphysiology
650	0	4	_aImmune Tolerance _xdrug effects
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aMale
650	0	4	_aMorphine _xpharmacology
650	0	4	_aMorphine Dependence _xcomplications
650	0	4	_aNarcotics _xpharmacology
650	0	4	_aNeuroimmunomodulation _xdrug effects
650	0	4	_aNeuropeptide Y _ximmunology
650	0	4	_aNucleus Accumbens _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Inbred Lew
650	0	4	_aReceptors, Dopamine D1 _xagonists
650	0	4	_aReceptors, Neuropeptide Y _xdrug effects
650	0	4	_aSpleen _xcytology
650	0	4	_aSympathetic Nervous System _xdrug effects
700	1		_aIjames, Stephanie G
700	1		_aLysle, Donald T
773	0		_tJournal of neuroimmunology _gvol. 177 _gno. 1-2 _gp. 18-26
856	4	0	_uhttps://doi.org/10.1016/j.jneuroim.2006.05.002 _zAvailable from publisher's website
999			_c16361596 _d16361596